Study of SG301 for Renal AMR After Transplantation

Clinical trial NCT07764627 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07764627
Sponsor: Hangzhou Sumgen Biotech Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Antibody Mediated Rejection

Start date: 2026-09-01
Primary completion: 2027-03-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.